Kanion Pharmaceutical
60055712.881.42% ( +0.18 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Kanion Pharmaceutical(600557) the Revenue is 831.27 M (-5.27%);the EBIT is 94.01 M (-6.38%);the EPS is 0.14 (-6.67%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.83B5.27%
----
----
EBIT
0.09B6.38%
----
----
EPS
0.146.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf